Among cancer care providers surveyed, 89% agreed cannabis can manage symptoms effectively, but only 15% considered themselves knowledgeable and only 30% routinely ask patients about use.
Oncology professionals, medical education developers, and cancer patients interested in provider perspectives on cannabis.
89% believe it works; 15% feel prepared
What the researchers found
A survey of cancer care network providers found 89% agree cannabis can manage cancer symptoms, 54% are sensitive to stigma around cannabis use (57% of their patients feel similarly), only 15% consider themselves knowledgeable, only 30% routinely ask about cannabis use, and 85% want to learn more.
Why it matters
There is a massive gap between provider belief in cannabis efficacy and their confidence discussing it with patients. This means patients using cannabis during cancer treatment may not be getting guidance from their care teams, creating potential safety risks.
The numbers in context
58% response rate (100/171 providers). 89% agree cannabis can manage symptoms. 30% ask about use. 15% consider themselves knowledgeable. 85% want to learn more. 54% sensitive to stigma.
How the study worked
Landscape survey of front-line providers in the MaineHealth Cancer Care Network, achieving a 58% response rate (100/171).
What this study cannot tell us
Single cancer care network in Maine with modest sample size. Self-reported knowledge and attitudes may not reflect actual clinical practice. The 42% non-response rate could introduce bias.
How to read the evidence
Single-network survey with good response rate but limited generalizability beyond one regional cancer care system.
When this study was published
2026 survey.
The bigger picture
As cannabis use among cancer patients increases, the knowledge gap among oncology providers becomes more consequential. This survey provides a baseline for the kind of education and training that cancer care networks need to implement.
Questions still open
- What educational formats would most effectively close the knowledge gap? Could standardized cannabis screening in oncology improve both patient care and research participation?
Common questions
Do oncologists support medical cannabis?
Why don't more doctors ask about cannabis use?
Read the original research
Survey of MaineHealth Cancer Care Network Providers on Cannabis Use: Preparation for Studies Sponsored by the National Cancer Institute.
Journal of Maine Medical Center, 8(1)
Citation
Prescott, Jill M; Saunders, Jamie G; Bradford, Leslie S; Remick, Scot C. (2026). Survey of MaineHealth Cancer Care Network Providers on Cannabis Use: Preparation for Studies Sponsored by the National Cancer Institute.. Journal of Maine Medical Center, 8(1). https://doi.org/10.46804/2641-2225.1245
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk